The Evi5 family in cellular physiology and pathology  by Lim, Yi Shan & Tang, Bor Luen
FEBS Letters 587 (2013) 1703–1710journal homepage: www.FEBSLetters .orgReviewThe Evi5 family in cellular physiology and pathology0014-5793/$36.00  2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.febslet.2013.04.036
⇑ Corresponding author at: NUS Graduate School of Integrative Sciences and
Engineering, National University of Singapore, 8 Medical Drive, Singapore 117597,
Singapore. Fax: +65 6779 1453.
E-mail address: bchtbl@nus.edu.sg (B.L. Tang).Yi Shan Lim a, Bor Luen Tang a,b,⇑
aDepartment of Biochemistry, Yong Loo Lin School of Medicine, National University Health System, Singapore
bNUS Graduate School of Integrative Sciences and Engineering, National University of Singapore, 8 Medical Drive, Singapore 117597, Singapore
a r t i c l e i n f oArticle history:
Received 25 February 2013
Revised 23 April 2013
Accepted 28 April 2013
Available online 10 May 2013
Edited by Lukas Huber
Keywords:
Cell cycle
Evi5
GTPase Activating Protein (GAP)
Raba b s t r a c t
The Ecotropic viral integration site 5 (Evi5) and Evi5-like (Evi5L) belong to a small subfamily of the
Tre-2/Bub2/Cdc16 (TBC) domain-containing proteins with enigmatically divergent roles as modula-
tors of cell cycle progression, cytokinesis, and cellular membrane trafﬁc. First recognized as a poten-
tial oncogene and a cell cycle regulator, Evi5 acts as a GTPase Activating Protein (GAP) for Rab11 in
cytokinesis. On the other hand, its homologue Evi5L has Rab-GAP activity towards Rab10 as well as
Rab23, and has been implicated in primary cilia formation. Recent genetic susceptibility analysis
points to Evi5 as an important factor in susceptibility to multiple sclerosis. We discuss below the
myriad of cellular functions exhibited by the Evi5 family members, and their associations with dis-
ease conditions.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The mouse gene locus Ecotropic viral integration site 5 (Evi5)
was ﬁrst identiﬁed as a common site for retroviral integration at
mouse chromosome 5 in T-cell lymphomas of recombinant inbred
AKXD mice with high incidences of lymphoma [1]. Pro-viral inte-
grations at the Evi5 locus disrupt a gene [2] – located 18 kb up-
stream of another common viral integration site, Growth factor
independence 1 (Gﬁ1) (which itself encodes a zinc ﬁnger-contain-
ing transcription factor involved in interleukin-2 signaling). The
human orthologue was separately identiﬁed as part of the consti-
tutional, reciprocal, t(1;10)(p22q21) translocation breakpoint in a
patient with stage 4S neuroblastoma. The corresponding gene on
chromosome 1p22, also named NB4S [3], encodes a 7.5 kbp tran-
script with an 810 amino acid open reading frame expressed in a
wide variety of tissues. A paralogue, known as Evi5 homologue
[4] or Evi5-like [5], shares about 70% identity to Evi5 and contains
the same domain structure, is located on mouse chromosome 8
and human chromosome 19 respectively.
Human and mouse Evi5 and Evi5-like encodes multiple alterna-
tively spliced transcripts. The longest polypeptide encoded by
these two proteins share two prominent domain features–a Tre-
2/Bub2/Cdc16 (TBC) domain [6] at the N-terminal half, as well as
a coiled-coil region that bears homology to Structural Maintenanceof Chromosomes (SMC) family of ATPases [7] at the C-terminal half
(Fig. 1). TBC domains are commonly associated with a functional
class of proteins that act as GTPase Activating Proteins (GAPs) for
the Rab family GTPases that regulate membrane trafﬁc [8]. SMC
proteins, on the other hand, are an evolutionarily conserved group
of molecules that are important in maintaining genome integrity
[7,9]. In eukaryotes, they are core components of the condensin
and cohesin complexes responsible for regulating chromosomal
condensation, pairing and segregation [10]. The physiological func-
tions of Evi5 are only beginning to be unraveled, and characteriza-
tion of Evi5’s localization and activities indicate that it may serve
different functions during the course of cell division by engaging
different interacting partners. Furthermore, Evi5L may be function-
ally distinct from Evi5 in spite of their high degree of homology.
We discuss in the paragraphs below, previously known and re-
cently revealed cellular activities exhibited by the Evi5 family
members, as well as their implicated or predicted involvements
in disease pathology.
2. Evi5 as a modulator of events during cell division
The initial reports describing the discovery of Evi5 shed little
light on its possible function other than hinting that the ubiqui-
tously expressed gene product, or truncated forms of it, could con-
tribute to oncogenesis, which is unsurprising given the link
between TBC domains and cell cycle regulation [2,3]. A subsequent
report indicated that Evi5 has a putative nuclear localizing signal
and exhibited a diffused nucleoplasm staining [11]. Interestingly,
Evi5 is a phosphoprotein and has a prominent centrosomal
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Fig. 1. Schematic diagram of human TBC1D20, Evi5 and Evi5L. Protein sequence analyses of complete sequences of human TBC1D20 (an example of a known RabGAP that
accelerates hydrolysis of Rab1), human Evi5 and human Evi5L, were carried out using two public domain software, Interpro (http://www.ebi.ac.uk/interpro/) protein
sequence analysis and classiﬁcation, and PSORT II prediction (http://psort.hgc.jp/form2.html). Boxes and arrows mark out the relative positions of TBC domains and the
coiled-coil domains. The numbers along the protein sequence depict the relative amino acid positions of where the respective regions begin. The multiple alignment analysis
was performed by ClustalW (http://embnet.vital-it.ch/software/ClustalW.html). Green highlighting marks residues that are identical between the TBC domains of TBC1D20,
Evi5 and Evi5L, pink highlights refer to conserved substitutions, while yellow highlights the semi-conserved substitutions.
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and c-tubulin. This differential subcellular localization patterns
indicate that Evi5 could potentially act in different compartments
of the cell.
Further work revealed that Evi5 undergoes several post-transla-
tional modiﬁcations, and has a dynamic association with mitotic
structures during the M phase [12]. It decorates the mitotic spindle
through anaphase and remains within the mid-zone and mid-body
until the completion of cytokinesis. The protein is phosphorylated
in early mitosis and undergoes proteolytic cleavage during late
mitosis and cytokinesis. Silencing of Evi5 resulted in a multinucle-
ate phenotype, suggesting a role for Evi5 in the completion of cyto-
kinesis. In this regard, it is intriguing that Evi5 was shown to
associate with the Chromosomal Passenger Complex (CPC) consist-
ing of Aurora B kinase, Inner Centromere Proteins (INCENP), survi-
vin and borealin [12]. The CPC acts in multiple processes during
mitosis that safeguards genomic integrity during cell division. Dur-
ing cytokinesis, while daughter cells are still connected by chromo-
some bridges, the CPC limits chromosomal damage by imposing an
abscission delay [13]. A recent report suggests that the CPC con-
trols abscission timing through Aurora B kinase mediated-phos-
phorylation and inhibition of the vacuolar-sorting protein Snf7
component of the Endosomal Sorting Complex Required for Trans-
port-III (ESCRT-III) polymerization and membrane association [14].
The exact role of Evi5 in cytokinesis, and whether it acts in this re-
gard via its association with the CPC, is still unknown. On the other
hand, another hypothesis proposed is that Evi5 exerts its effect in
cytokinesis via its control of Rab11 activity [15,16]. This shall be
discussed in more detail below.
Evi5 has also another implicated role in the earlier phases of the
cell cycle – as a regulator of cyclin accumulation via its effects onthe stability of Early mitotic inhibitor 1 (Emi1) accumulation [4].
Emi1 is an inhibitor of anaphase promoting complex/cyclosome
(APC/C) complex, and together with either of its activators Cdc20
or Cdh1, sustain levels of APC/C’s cyclin substrates [17,18]. Even
in the absence of transcription factor E2F activation and basal lev-
els of cyclin A transcription, Emi1’s overexpression is apparently
sufﬁcient to drive S phase by stabilizing cyclin A [18]. Before mito-
sis, at the G1/S phase and throughout the S phase, Evi5 binds to a
site adjacent to Emi1’s degron, blocking degron phosphorylation by
Polo-like kinases (Plks) [4], particularly Plk1 [19], thereby allowing
the accumulation of Cyclin A for the progression of S phase [20].
Upon the onset of mitosis, phosphorylation of Emi1 leads to degra-
dation by the Skp, Cullin, F-box (Fb) containing protein (SCF) E3
ubiquitin ligase complex, one of which consists of a b-transducin
repeat containing protein (bTrCP)/Fbw1a [21]. Finally, phosphory-
lated Evi5 and Emi1 are then destined for ubiquitination and deg-
radation by the 26S proteasome. Hence, Evi5 effectively maintains
Emi1 levels in the S/G2 phase. Evi5 silencing induces aberrant and
untimely degradation of Emi1, resulting in a sequence of events
ranging from premature APC/C activation and cyclin destruction,
culminating in cell-cycle arrest and mitotic catastrophe. Taken to-
gether, by acting through different interacting partners, Evi5 is able
to exert varying inﬂuences on cell cycle progression (Fig. 2).
3. Evi5 as a Rab11 GAP
The Rab family of small GTPases regulate a myriad of mem-
brane transport processes in the eukaryotic cell [22,23] via their
engagement of effector molecules such as motors, tethering fac-
tors, coat proteins and membrane fusion factors [24–27] in their
active GTP-bound form. Two classes of proteins principally
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Fig. 2. Evi5’s role in early stages of the cell cycle. Evi5 is a regulator of cyclin accumulation via its effects on the stability of the Early mitotic inhibitor 1 (Emi1) [4], the latter
being an inhibitor of anaphase promoting complex/cyclosome (APC/C) complex. Before mitosis, at the G1/S phase and throughout the S phase, Evi5 binds to a site adjacent to
Emi1’s degron, blocking its phosphorylation by Polo-like kinase 1 (Plk1), thereby allowing the accumulation of Cyclin A for the progression into S phase. Cyclin B/Cdk1
appears to ‘‘prime’’ or enhance the phosphorylation of Emi1 by Plk1 [19]. Plk1 is also able to stimulate the phosphorylation of Evi5. Upon the onset of mitosis, Emi1 levels are
regulated via degradation by the Skp, Cullin, F-box (Fb) containing protein (SCF) and b-transducin repeat containing protein (bTrCP) E3 ubiquitin ligase complex [21].
Phosphorylated Evi5 and Emi1 are then destined for ubiquitination and degradation by the 26S proteasome. See text for relevant references and sources.
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nucleotide Exchange Factors (GEFs) and GTPase Activating Proteins
[28]. GEFs catalyze the GTP–GDP exchange of the Ras superfamily
of small GTPases to effectively activate them [29]. A small number
of Rab GEFs since identiﬁed have been found to be largely structur-
ally unrelated to each other. However, certain Rab GEFs do form
small functional subfamilies that are distinguishable by signature
domains such as Vacuolar protein sorting 9 (Vps9) [30] and differ-
entially expressed in normal and neoplastic cells (DENN) [31]
domains.
The intrinsic GTP hydrolysis activity of Rab proteins is usually
very low, and requires enzymatic activity induced by their respec-
tive Rab GAP proteins. GAPs are important in enhancing hydrolysis
of the GTP-bound Rab, thereby switching activated Rabs to the
inactive state [32]. These proteins therefore serve to restrict spatial
and temporal overlap of Rabs, by mediating sequential steps of
membrane transport [33]. Compared to GEFs, known Rab GAPs
are somewhat less diverse, with Tre-2/Bub2/Cdc16 (TBC) do-
main-containing proteins expected to function as a Rab GAP
[8,28]. The TBC domain was ﬁrst recognized as a domain that
was conserved among the tre-2 oncogene product and yeast cell
cycle regulators Bub2 and Cdc16, beginning with the cloning of
mammalian TBC1 [34], has to date been discovered in more than
40 other proteins in humans and mice [8]. The GAP of Ypt6p
(Gyp6p), the ﬁrst Rab GAP, was cloned from yeast [35]. Several oth-
ers, including those from mammals acting principally on Rab5 and
Rab6, were subsequently identiﬁed [36–40]. A yeast 2-hybrid-
based screen and subsequent in vitro Rab GAP activity assays iden-
tiﬁed seven TBC domain-containing proteins that interact with
speciﬁc Rabs, of which a fraction of these proteins exhibit signiﬁ-
cant Rab GAP activity [5]. Although the TBC domain is proposed
to be important for Rab interaction and best known as the Rab-
GAP domain, a recent protein interaction screen for Rab effectors
(i.e. which binds to the activated form of Rabs) identiﬁed three
known GAPs, namely, mKIAA1055/TBC1D2B (Rab22-binding pro-
tein), GAPCenA/TBC1D11 (Rab36-binding protein) and centaurin
b2 (Rab35-binding protein, which does not contain a TBC domain).
Notably, all these three GAP proteins appear to interact with their
speciﬁc Rabs via a domain other than the TBC domain [41].
Incidentally, two reports that were published in 2007 both
demonstrated Evi5’s interaction with members of the Rab11 fam-
ily, also drew differing conclusions with regards to Evi5’s GAP
activity towards Rab11. The earlier paper by Westlake andcolleagues showed through genetic and biochemical interaction
assays that Evi5 binds Rab11a and Rab11b in a GTP-dependent
manner, but exhibited no GAP activity towards Rab11 in in vitro
assays [42]. Despite that, endogenous Evi5 co-localizes with
Rab11 in a complex in vivo and overexpression of Rab11 redistrib-
utes centrosomal cytoplasmic-localized Evi5 to Rab11-positive
recycling endosomes, in U2OS cells, thus suggesting a relationship
between Rab11 and Evi5. Also, Rab11 effector proteins such as
Rab11 family interacting protein 3 (Rab11-FIP3), which bind to ac-
tive, GTP-bound Rab11, could compete with Evi5 for Rab11 bind-
ing. Another paper by Dabbeekeh et al. also found that during
interphase in the HeLa cell model, Rab11 and Evi5 co-localized at
the pericentriolar region. Furthermore, Evi5 was shown to interact
with Rab11 in a GTP-enhanced manner via its TBC domain. Con-
trary to the previous report, these authors conﬁrmed that Evi5
exhibited speciﬁc Rab GAP activity in vitro towards Rab11 (in com-
parison with similarly endosome-localized Rab4) [43].
4. Evi5’s association with the Rab11 subfamily of Rab GTPases
The Rab11 subfamily (Rab11a, Rab11b and Rab25) and their
effectors [44] mediate trafﬁcking steps at and from the recycling
endosome [45,46] of a large variety of molecules such as ligand
transporters [47,48], ion channels [49–51] signal receptors [52–
58], cell adhesion molecules [59,60] and others [61]. Endosomal
recycling activities mediated by the Rab11 subfamily are key
events in various physiological processes such as regulation of cell
polarity [62], cell fate determination [63], tissue morphogenesis
[64,65], primary ciliogenesis [66], autophagy [67], membrane traf-
ﬁcking and cytokinesis [15,16,68,69], and cell migration [70,71].
Disruption of Rab11-mediated trafﬁc could underlie pathologies
associated with neurodegenerative disorders such as Huntington’s
disease [72,73], while aberrant Rab11 family-mediated trafﬁc have
been associated with cancer cell migration and invasion [60,74].
Evi5’s interaction with Rab11 suggests that it could potentially
have a wide range of physiological and developmental roles, many
of which still lack elucidation. Foremost, Evi5 may play an impor-
tant role in the regulation of abscission via Rab11 and Rab11-FIP3,
because silencing of Evi5 by RNA interference disrupted localiza-
tion of Rab11-FIP3 complexes at abscission sites of all randomly se-
lected cells undergoing ﬁnal stages of cytokinesis [42]. During cell
division, Rab11-FIP3 has been implicated in the membrane deliv-
ery from endosomal recycling compartments to sites of membrane
1706 Y.S. Lim, B.L. Tang / FEBS Letters 587 (2013) 1703–1710insertion (Fig. 3). Detailed analysis of the roles played by Evi5 dur-
ing cytokinesis could potentially be complicated by its apparent
involvement in the earlier stages of the cell cycle, as discussed in
the previous section. The understanding Evi5 and Rab11’s possible
role in cell migration has recently been further deepened. An RNAi-
based screen for Rab GAPs involved in collective cell migration of
Drosophila melanogaster border cells (BCs), which has been known
to be dependent on protein trafﬁcking, identiﬁed the ﬂy orthologue
of Evi5 as a key regulator of the BC migration [75]. Evi5 acts
through Rab11, functioning as a Rab GAP for Rab11. In BC migra-
tion towards the oocyte, polarized spatial localization of receptor
tyrosine kinase (RTK) activity at the leading edge is required. More-
over, an earlier paper by the same group showed that Rab11 is
essential in controlling the activation of RTKs at the leading edge
of these cells [76]. Both overexpression and depletion of Drosophila
Evi5 abolished enrichment of phosphotyrosine signals at the front
of the cell cluster, indicating that stringent regulation of Rab11
activity is necessary for the proper spatial restriction of activated
signaling receptors [75]. Acting as a Rab GAP of the Rab11 family
therefore, Evi5 plays clear and important roles in modulating cyto-
kinesis and cell migration during development.
5. Evi5 in human diseases
The association of Evi5 with important cell cycle and cell migra-
tion regulators suggests its involvement in the pathology of certain
diseases. Early work associated with Evi5’s identiﬁcation points to-
wards its role as an oncogene or tumor suppressor [2,3]. This no-
tion is strengthened by its interactions with Emi1 and Rab11,
with an apparent role in the regulation of the cell cycle through
interaction with the aurora-B kinase protein complex [4,12]. How-
ever, direct evidence for Evi5’s role in oncogenesis, or suppressionRecycling 
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Fig. 3. Evi5’s role in cytokinesis. Rab11a (Rab11) and Evi5 have both been localized to
Rab11a, together with its effectors (Rab11-FIP), are required to target recycling endoso
important for cytokinesis. Evi5’s presence at the interphase centrosomes and recycling e
prophase, Evi5 appears to have a cytoplasmic localization. However in metaphase, Evi5 b
midbody at the ﬁnal stages of mitosis. At these late stages Evi5 also interacts with the Ch
for the completion of cytokinesis [12]. From the different views on Evi5’s localization, it i
differing roles depend critically on its spatial or temporal localization (that are in turn rof tumorigenesis, is still lacking. Evi5 has been found to be overex-
pressed in certain cancer types [77,78]. For instance, Evi5 could
serve to prevent exhaustion of hematopoietic stem cells, whose
levels are elevated as a result of the loss of tumor suppressor
Runt-related transcription factor 1 (RUNX1) [78]. This suggests
that elevated Evi5 levels could promote leukemia in cooperation
with a loss of RUNX1. It is also conceivable that loss of Evi5 may
enhance cancer cell invasion and metastasis via an enhanced
Rab11 family GTPase activity, but this possibility remains to be
clearly demonstrated.
An unexpected Evi5 disease link has arose from recent genomic
analyses, which implicated Evi5 as a risk factor for multiple sclero-
sis (MS), a rather common autoimmune demyelinating disease
with multiple neurological symptoms [79]. MS has a modest de-
gree of heritability, and the Human Leukocyte Antigen (HLA) re-
gion is a known strong susceptibility locus for MS [80]. Genome-
wide association studies have since identiﬁed other susceptibility
genes, including CD25, CD58, CLEC16a, Interleukin-2 Receptor a
(IL2RA), Interleukin-7 Receptor (IL7R), G5 (GPC5), Regulator of G
protein Signaling 1 (RGS1), and Tyrosine Kinase 2 (TYK2) [81–83],
with some of these genes having clear functions in T-cell-mediated
immunity.
Several separate analyses have associated single nucleotide
polymorphisms (SNPs) of Evi5 with increased MS susceptibility
[82,84–89]. The molecular basis of this association is unclear, as
a role for Evi5 in T-cell mediated immunity has not yet been ex-
plored extensively. However, it is conceivable that Evi5 could affect
aspects of innate immunity such as toll-like receptor signaling
through Rab11, which was shown to be responsible for transport
of the receptor via recycling endosomes [57]. A recent analysis of
enhancer elements bound by the CCCTC-binding protein (CTCF)
indicated that MS susceptibility SNPs within the last intron ofMidbody
Rab11
Vesicle Rab11- 
FIP
CPC
the pericentriolar region in U2OS cells (the cross indicated as ‘C’ in the diagram).
mes to the midbody or cleavage furrow, carrying physical membrane and factors
ndosomes could inhibit FIP’s promotion of cytokinesis [42]. It was also noted that in
ecome associated with the mitotic spindles and it moves to the spindle midzone and
romosomal Passenger Complex (CPC) INCENP-Aurora kinase B (AURKB)-survivin (S)
s possible that Evi5 plays not one, but possibly several roles in cell division, with the
egulated by ubquitination and degradation).
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expression of the neighboring gene and not Evi5 itself [89]. That
Gﬁ1 and not Evi5 being the causal gene for MS susceptibility, at
least pertaining to some of the SNPs, makes intuitive sense, as
Gﬁ1 is a known regulator of lymphocyte development and activa-
tion [90].
6. Functional roles of Evi5-like (Evi5L)
While Evi5 has been implicated in a variety of roles and several
diseases, the function of Evi5L, a paralogue of Evi5, is more elusive.
It bears approximately 70% homology to Evi5, and hence would be
expected to interact to some degree with Evi5 interacting partners,
yet, no interaction has been demonstrated. Unlike Evi5, Evi5L ap-
pears to be largely cytosolic throughout the cell cycle, but has an
interesting apparent concentration at the pericentriolar region
(Fig. 4). Evi5L was ﬁrst shown to bind Rab10 and exhibits in vitro
GAP activity towards the small GTPase [5]. Rab10 is important in
the regulation of endocytic recycling, and has been implicated in
multiple roles that include basolateral recycling of clathrin-inde-
pendent cargo in Caenorhabditis elegans intestine [91], AMPA-type
glutamate receptors in post-synaptic membranes [92], basolateral
recycling in polarized Madin–Darby canine kidney (MDCK) cells,
Glut4 transporter trafﬁcking in response to insulin [93], Toll-like
receptor 4 (TLR4) signaling [94], phagosome maturation [95], and
ciliary transport [96]. Notably, except for primary ciliogenesis,
the role of Evi5L in these processes has not yet been demonstrated.
The primary cilium is a singular cellular projection protruding
from the surface of cells that concentrates various signaling recep-
tors and molecules. Hence, it is considered to be a signaling nexus
that plays key roles in cellular physiology and organism develop-
ment [97,98]. In fact, defects in the primary cilium’s functional
and trafﬁcking components underlie multiple human ciliopathies
[99]. Screening for Rab GAPs that affect primary cilium formation,
Barr and colleagues identiﬁed Rab8a, 17, and 23, and their cog-
nate GAPs, XM_037557, TBC1D7, and EVI5L. Carried out in the hu-
man telomerase-immortalized retinal pigmented epithelial
(hTERT-RPE1) cell model, cells overexpressing Evi5L signiﬁcantlyFig. 4. Subcellular localization of Evi5L. Top panel: A magniﬁed image of Evi5L in NIH3
Evi5L (red) appears to have a generally diffused cytosolic staining in NIH3T3 mouse ﬁbrob
cilium marker, and also labeled with Pericentrin (Abcam; ab4448) (magenta). Botto
overexpressing both mouse Arl13b-GFP (green) and human Evi5L (Openbiosystems: M
Evi5L (ab88915) (red). In both panels of images, primary cilia were induced after treatm
Evi5L staining exhibits a partial co-localization with the pericentrin staining. Scale bar =reduced primary cilium formation by more than half [100]. In the
in vitro GAP activity assays, the authors showed that Evi5L espe-
cially exhibited speciﬁc activity towards Rab23, but not Rab10.
Rab23 was ﬁrst isolated based on a mouse mutation to a gene
whose functions antagonized Sonic hedgehog (Shh) signaling dur-
ing embryonic development [101]. Shh signaling is critically
dependent on the primary cilia, as proper functioning of ciliary
intraﬂagellar transport (IFT) processes are essential for Shh signal-
ing [102,103], and key components of the Shh signaling pathway,
such as the Gli family of transcription factors and smoothened,
are enriched at the primary cilia [104,105]. Although Rab23 has
not yet been shown to be critical for ciliogenesis and ciliary trans-
port as shown for Rab8a [106,107] and Rab11 [66], it is known to
inﬂuence the levels of smoothened in the cilium [108]. Notably,
in humans, Rab23 mutations underlie the pathological phenotypes
associated with Carpenter’s syndrome [109], whose phenotypes
bear resemblance to those found in some ciliopathies, especially
obesity, polydactyly and certain malformations of the brain
[109]. Although the exact ciliary cargo involved and transport step
mediated by Rab23 and Evi5L are yet unclear, accumulating evi-
dence suggest that they have important roles in speciﬁc ciliary
transport.
7. Future perspectives
We have summarized and discussed above cellular and physio-
logical activities and roles of the Evi5 family of TBC proteins. The
tumorigenic (or tumor suppressive) activity of Evi5 requires fur-
ther clariﬁcation. Its ability to prevent hematopoietic stem cell
exhaustion [78] suggests that Evi5 might have a more general role
in adult stem cells. It is also not known if Evi5 has a direct role in
cancer cell migration and invasion via its interaction with
Rab11GTPases and the Rab coupling protein (RCP) [110]. Many po-
tential functional aspects of Evi5 and Evi5L remain unexplored.
One possibility pertains to a plausible role for Evi5 in ciliary trans-
port and ciliogenesis via its GAP activity on Rab11 [66]. A recent re-
port showed that Evi5 levels are dramatically elevated during
blastema formation in salamander limb regeneration [111]. TheT3 mouse ﬁbroblasts using an Evi5L antibody from Abcam (ab88915). Endogenous
lasts. Cells are transfected with Arl13b-GFP (Origene: MG206808) (green), a primary
m panel: A magniﬁed image of an NIH3T3 mouse ﬁbroblast that is transiently
HS1011-76129), and co-stained with Pericentrin (Abcam; ab4448) (magenta) and
ent with 24 h of serum starvation media. From the panel of images, it appears that
5 lm.
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ferentiated cells in the G1/S/G2 phases of the cell cycle until they
have accumulated under the wound epidermis, with entry into
mitosis subsequently triggered by growth factors. It would be
interesting to see if Evi5 levels are also similarly elevated during
regenerative attempts in mammalian tissues, which we know have
a vastly inferior regenerative capacity compared to amphibians.
Similarly, it would also be interesting to investigate Evi5’s role in
cell migration during wound healing.
While activity of Evi5 may be restricted by its nuclear and cen-
trosomal localization [11], Evi5L is largely cytosolic, with some
concentration around the pericentriolar region (Fig. 3). It could
conceivably participate in trafﬁcking events in multiple membrane
compartments. While its overexpression clearly affects primary
ciliogenesis [100], its exact mode of function is unclear. Although
Evi5L exhibits speciﬁc Rab23 GAP activity in vitro, Evi5L’s role in
Shh signaling has not been reported. Moreover, whether it func-
tions strictly through Rab23 is unclear. Alternatively, its suspected
in vitro interaction with Rab10, reported by one group [5] but not
another, is worth further exploration. Thus far, Evi5 and Evi5L ap-
pears to have non-overlapping Rab targets and functions, it would
be interesting to see if these could, at least in some cases, comple-
ment the deﬁciency of each other when overexpressed.
Investigating the possible underlying cellular mechanisms of
how Evi5 polymorphisms inﬂuence onset and progression of dis-
eases such as MS would be of translational importance. Current
animal models of MS mimic disease pathology, but not its genesis.
It would be worth checking if transgenic expression of Evi5 and
Gﬁ1, or their speciﬁc ectopic expression in the central nervous sys-
tem in animal models will either produce MS pathologies, or en-
hance the susceptibility to MS induced by neurochemical means.
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